Clinical Trial Update: A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease [Phase 3]

View source ↗

Summary

Clinical trial update for lecanemab in early Alzheimer's disease, a Phase 3 study currently listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LEQEMBI (lecanemab)

Snippet

Sponsor: Eisai Inc. | Conditions: Early Alzheimer's Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING